Skip to content

Transcutaneous Carbon Dioxide Monitoring Post Cardiac Surgery: Incidence and Severity Resp Insufficiency

Pilot Study: Transcutaneous Carbon Dioxide Monitoring Post Cardiac Surgery: Incidence and Severity of Respiratory Insufficiency

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01188590
Enrollment
50
Registered
2010-08-25
Start date
2009-11-30
Completion date
2010-01-31
Last updated
2016-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Insufficiency

Keywords

Post operative Respiratory insufficiency

Brief summary

The purpose for the investigators study is to investigate the severity and incidence of respiratory insufficiency using transcutaneous carbon dioxide (TcPCO2) monitoring as an adjunct to the current standard of care for early detection of inadequate ventilation in post-operative surgical in-patients undergoing cardiac surgery after discharge from intensive care unit (ICU) or post anesthesia recovery unit (PACU).

Detailed description

This observational study is to determine the baseline carbon dioxide and severity of respiratory distress and acute respiratory failure (ARF)/respiratory arrest in the post cardiac surgery patients in the first 24 hours on a monitored telemetry floor.

Interventions

DEVICETOSCA 500 monitor

transcutaneous ear lobe probe that monitors pulse rate, oxygen saturation and carbon dioxide levels

Sponsors

Baylor Research Institute
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* ASA Class 1, 2, 3, or 4 men and women who are having cardiac surgery by one of the participating surgeons

Exclusion criteria

1. Subject has participated in a trial with any experimental drug or device trial within 30 days prior to enrollment in the study, or has ever been enrolled in this study; 2. Subject has a condition that would require an extensive amount of time off of 13 Roberts during the first 24 hours of admission to the telemetry unit. (e.g., hemodialysis); 3. Subject has a condition or allergy which would prohibit placing the probe on the earlobes; 4. Subject is unable to undergo any procedure required by the protocol; 5. Subject has any other condition or factor which, in the Investigator's opinion, might increase the risk to the subject; or 6. If female, subject is non-lactating, and is either: * Not of childbearing potential, defined as postmenopausal for at least 1 year or surgically sterile due to bilateral tubal ligation, bilateral oophorectomy, or hysterectomy; or * Of childbearing potential but is not pregnant as confirmed by negative serum pregnancy test at time of screening.

Design outcomes

Primary

MeasureTime frame
Determine the baseline TcPCO2 levels for first 24 hours post ICU of cardiac surgery patients.24 hours

Secondary

MeasureTime frame
Classify levels of hypercarbia found24 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026